News

UAE becomes world's second country to approve "Itvisma" following US FDA.

H.E. Dr. Fatima Al Kaabi: EDE is committed to establishing a regulatory environment that supports innovation, ensures patient safety, and enhances clinical research

MoU to support localisation of industries and facilitate technology transfer between pharmaceutical companies.

Initiative reviews regulatory frameworks while fostering dialogue to enhance pharmaceutical system efficiency and innovation

Her Excellency Dr. Fatma Al Kaabi, Director General of the Emirates Drug Establishment, stressed that Eid Al Etihad is a great national occasion to honor the legacy of the Founding Fathers, who laid the foundations of a strong and united nation and built a development model that continues to inspire generations. Today, under the leadership of President His Highness Sheikh Mohamed bin Zayed Al Nahyan, this legacy endures through a wise vision that shapes the future and upholds the timeless values of humanity.

H.E. Dr. Fatima Al Kaabi, Director General of the Emirates Drug Establishment, stressed that Commemoration Day is a promise and a pledge that the sacrifices of the UAE’s sons will forever remain in our nation’s record of glory, alive in our hearts and inspiring us to continue the path of giving and development.

Initiative, launched in partnership with the pharmaceutical sector aims to enhance patient safety and pharmaceutical regulatory excellence

H.E. Fatima Al Kaabi: Flag Day fuels our commitment to drive innovation and progress in the pharmaceutical sector

Emirates Drug Establishment Signs MoU with Korean Ministry of Food and Drug Safety